logo
logo
Sign in

Tetanus Toxoid Vaccine Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2026

avatar
Hannah Edwards
Tetanus Toxoid Vaccine Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2026

The rise in the number of reported cases of tetanus and diphtheria in the developing countries will be the major factor influencing the market growth.

The global tetanus toxoid vaccine market is expected to reach USD 6.46 Billion by 2026, according to a new report by Reports and Data. This can mainly be contributed by the rise in number of reported cases of tetanus and diphtheria in the developing countries. The low costs of the vaccine, as well as the increasing government initiatives towards technological improvements regarding immunization and vaccination, are also fuelling the growth of the market.

Several vaccine combinations include the tetanus vaccine such as Diphtheria, Tetanus, and Pertussis (DTaP); Monovalent Tetanus Toxoid (TT); Tetanus, Diphtheria, And Pertussis (Tdap); Diphtheria and Tetanus (DT); and others. DTaP and DT are used as a pediatric vaccine for children less than seven years old while Tdap and Td are given to those who are seven years old and above, where the lowercase, ‘d’ and ‘p’ denote the lower strengths of diphtheria and pertussis vaccines.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1287

Further key findings from the report suggest

  • The market is segmented on the basis of vaccine type into Diphtheria, Tetanus, and Pertussis (DTaP); Monovalent Tetanus Toxoid (TT); Tetanus, Diphtheria, And Pertussis (Tdap); Diphtheria and Tetanus (DT); and others. DTaP vaccines occupy the highest market share in the year 2018 and are forecasted to maintain its dominance throughout the forecast period, with a CAGR of 5.3%, owing to several initiatives and investments by governments to eradicate these diseases.
  • The market is segmented on the basis of age group into adults and pediatrics. The adult segment is forecasted to have a higher growth rate of 6.3% during the forecast period. The demand for Tdap and Td vaccines among adults, particularly Tdap during pregnancy will fuel the need for the tetanus toxoid vaccine in adults.
  • The market is segmented on the basis of geography into North America, Europe, Asia Pacific, Latin America, and MEA. North America accounted for the largest share of ~32% of the market in 2018. The region has a well-established and advanced vaccination program and the presence of a large number of market players.
  • Key participants include Merck & Co. Inc., GlaxoSmithKline Plc., Sanofi Pasteur, Inc., Pfizer, Inc., Bharat Biotech, AstraZeneca Plc., Valeant Pharmaceuticals, Shenzhen Kangtai Biological Products, Astellas Pharma Inc., Emergent Biosolutions Inc., and Panacea Biotec, among others.

 Segments covered in the report:

On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. According to the analysis, North America is expected to dominate the market with the highest market share. Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.

Vaccine type Outlook (Volume, Kilo tons; 2018-2026 and Revenue, USD Billion; 2018-2026)

  • Monovalent Tetanus Toxoid (TT)
  • Diphtheria, Tetanus, and Pertussis (DTaP)
  • Diphtheria and Tetanus (DT)
  • Tetanus, Diphtheria, And Pertussis (Tdap)
  • Others

Dosage Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)

  • Quadrivalent
  • Pentavalent
  • Hexavalent

Age group Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)

  • Paediatric Vaccines
  • Adult Vaccines

End users Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)

  • Hospitals And Clinics
  • Government Organizations
  • Research
  • Others

 Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1287

Beneficial Aspects of the Report:

  • Global and region forecast of the Tetanus Toxoid Vaccine market from 2020-2027
  • In-depth analysis of market dynamics, industry outlook, market size based on types and applications
  • Details of value chain analysis, supply and demand ratio, production and consumption patterns
  • SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide a better understanding of the market and competitive players
  • Detailed insights on competitive landscape and emerging market trends

To read more  about the report – https://www.reportsanddata.com/report-detail/tetanus-toxoid-vaccine-market

Thank you for reading our report. Reports and Data provides customization of the report as per the needs of the clients. For further inquiry on customization, please connect with us and our team will ensure the report is tailored to fit your requirements.

Browse More Reports:-

Hernia Mesh Market Share

Spun Bond Non-Woven Market Size

collect
0
avatar
Hannah Edwards
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more